Delay in diagnosis of cancer. Possible effects on the stage of disease and survival


Abstract
A total of 2299 new cancer patients were referred to the Northern Israel Oncology Center in 1974 and in 1980. The stage of disease, delay in diagnosis, the responsibility for the delay, and the survival of those referred in 1974 were investigated. At the time of diagnosis, 39% of the patients had localized disease, 34% had locally advanced disease, and 23% had metastatic disease. In 52% of the patients there was no delay in diagnosis. No correlation was found in the group as a whole between the stage of disease and delay in diagnosis. Only in the breast cancer group without delay in diagnosis, however, were there significantly more patients at an early stage than at an advanced stage of disease. At each stage of disease, responsibility for the delay was shared about equally between the patients and the physicians, except in advanced breast cancer, where the patients were more often responsible for the delay. The survival rate was higher in patients in whom the disease was diagnosed earlier. It was also higher at each clinical stage (Stages I and II) in patients who had no delay than in those with delay in diagnosis. The survival rate was higher in patients who were themselves responsible for the delay in diagnosis than in patients whose physicians were responsible for the delay. In 1980, less diagnoses were delayed in fewer patients than in 1974 (42% versus 65%). Responsibility for the delay in 1980 lay equally with the patients and with the physicians, but when compared to 1974, the physicians' responsibility and administrative delay were less. Campaigns for early diagnosis are advocated.

 

Free consultation on your medical malpractice claim


MEDICAL MALPRACTICE LINKS  

Failure to diagnose cancer, doctor's defenses Malpractice and standard of care
Failure to Detect Lung Cancer claims
What is cancer (chapter one from our upcoming book, A Complete Guide to Lung Cancer) 
medical malpractice and standard of care (a journal discussing medical malpractice standards of care including failure to diagnose cancer)
New York medical malpractice claims

medical malpractice lung cancer claims      cancer malpractice statute of limitations               
New York Cancer Malpractice claims         medical malpractice and clinical practice guidelines
New Jersey cancer malpractice claims       medical malpractice liability

Medical malpractice jury instruction          New York Medical malpractice law 
medical malpractice pre-existing cause     workers' compensation doctor liability for malpractice

malpractice and informed consent            lung cancer malpractice claim elements

Delayed diagnosis of cancer Kern article    Cancer pathology claims
Delayed diagnosis of cancer Sign article    Errors in Cancer Diagnosis

 


How to contact us:
Law Offices of Howard A. Gutman,
230 Route 206, Mount Olive, New Jersey 07836
(973) 598-1980, E-mail
Howian@aol.com 

New York Office
305 Madison Avenue, Suite 449
New York, New York 10165 (212) 886-4838

Hit Counter

 

We offer a free telephone consultation to discuss your case. Please feel free to call or e-mail our office.

keywords: medical malpractice, claim,  attorney, failure to diagnose cancer, negligence, malpractice, delayed diagnosis, standard of care, 
missed diagnosis, New Jersey medical malpractice lawyer, New York medical malpractice lawyer.

About Us
 

Mr. Gutman is the author of Lung cancer and Mesothelioma (2006), a 480 page book which is entering its second edition.  The detailed book reviews chemotherapy, emerging gene therapy, radiation, experimental treatments for lung cancer, and medical malpractice questions.   Mr. Gutman served as a caregiver for a family member with lung cancer, was a member of the board of directors of a leading cancer support group, and is an attorney specializing in lung cancer legal issues.  He combines the intellectual knowledge of someone who handles issues of lung cancer with the personal approach of someone who has dealt with cancer and confronted many of the difficult questions patients and family members confront.     
                      
 

 Lung Cancer and Mesothelioma